In silico structure-based optimisation of pyrrolidine carboxamides as Mycobacterium tuberculosis enoyl-ACP reductase inhibitors: = In silico Struktur-basierte Optimierung von Pyrrolidin-Carbonsäureamiden als Mycobacterium tuberculosis Enoyl-ACP-Reduktase-Inhibitoren
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis Book |
| Language: | English |
| Published: |
Würzburg
2017
|
| Subjects: | |
| Online Access: | Volltext |
| Item Description: | veröffentlicht 2018 |
| Physical Description: | xix, 355 Seiten Illustrationen, Diagramme |
Staff View
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV045009509 | ||
| 003 | DE-604 | ||
| 005 | 20180702 | ||
| 007 | t | ||
| 008 | 180615s2017 a||| m||| 00||| eng d | ||
| 035 | |a (DE-599)BVBBV045009509 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-384 |a DE-473 |a DE-703 |a DE-1051 |a DE-824 |a DE-29 |a DE-12 |a DE-91 |a DE-19 |a DE-1049 |a DE-92 |a DE-739 |a DE-898 |a DE-355 |a DE-706 |a DE-20 |a DE-1102 |a DE-860 |a DE-2174 | ||
| 084 | |a VS 5070 |0 (DE-625)159664: |2 rvk | ||
| 100 | 1 | |a Narkhede, Yogesh |d ca. 21. Jh. |e Verfasser |0 (DE-588)1161195408 |4 aut | |
| 245 | 1 | 0 | |a In silico structure-based optimisation of pyrrolidine carboxamides as Mycobacterium tuberculosis enoyl-ACP reductase inhibitors |b = In silico Struktur-basierte Optimierung von Pyrrolidin-Carbonsäureamiden als Mycobacterium tuberculosis Enoyl-ACP-Reduktase-Inhibitoren |c submitted by: Yogesh Narkhede from Nasik, India |
| 246 | 1 | 1 | |a In silico Struktur-basierte Optimierung von Pyrrolidin-Carbonsäureamiden als Mycobacterium tuberculosis Enoyl-ACP-Reduktase-Inhibitoren |
| 264 | 1 | |a Würzburg |c 2017 | |
| 300 | |a xix, 355 Seiten |b Illustrationen, Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a veröffentlicht 2018 | ||
| 502 | |b Dissertation |c Julius-Maximilians-Universität Würzburg |d 2017 | ||
| 546 | |a Zusammenfassung in deutscher und englischer Sprache | ||
| 650 | 0 | 7 | |a Pyrrolidinderivate |0 (DE-588)4176525-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Tuberkelbakterium |0 (DE-588)4186384-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Enoyl-acyl-carrier-protein-Reductase |g Enoyl-[acyl-carrier-protein]-Reductase |0 (DE-588)4481400-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Tuberkelbakterium |0 (DE-588)4186384-7 |D s |
| 689 | 0 | 1 | |a Enoyl-acyl-carrier-protein-Reductase |g Enoyl-[acyl-carrier-protein]-Reductase |0 (DE-588)4481400-8 |D s |
| 689 | 0 | 2 | |a Pyrrolidinderivate |0 (DE-588)4176525-4 |D s |
| 689 | 0 | 3 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe, PDF |o urn:nbn:de:bvb:20-opus-152468 |
| 856 | 4 | 1 | |u https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-152468 |x Resolving-System |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030401469 | ||
Record in the Search Index
| _version_ | 1804178621004251136 |
|---|---|
| any_adam_object | |
| author | Narkhede, Yogesh ca. 21. Jh |
| author_GND | (DE-588)1161195408 |
| author_facet | Narkhede, Yogesh ca. 21. Jh |
| author_role | aut |
| author_sort | Narkhede, Yogesh ca. 21. Jh |
| author_variant | y n yn |
| building | Verbundindex |
| bvnumber | BV045009509 |
| classification_rvk | VS 5070 |
| collection | ebook |
| ctrlnum | (DE-599)BVBBV045009509 |
| discipline | Chemie / Pharmazie |
| format | Thesis Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02381nam a2200445 c 4500</leader><controlfield tag="001">BV045009509</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20180702 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">180615s2017 a||| m||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV045009509</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-384</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-1051</subfield><subfield code="a">DE-824</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-1049</subfield><subfield code="a">DE-92</subfield><subfield code="a">DE-739</subfield><subfield code="a">DE-898</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-706</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-1102</subfield><subfield code="a">DE-860</subfield><subfield code="a">DE-2174</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 5070</subfield><subfield code="0">(DE-625)159664:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Narkhede, Yogesh</subfield><subfield code="d">ca. 21. Jh.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1161195408</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">In silico structure-based optimisation of pyrrolidine carboxamides as Mycobacterium tuberculosis enoyl-ACP reductase inhibitors</subfield><subfield code="b">= In silico Struktur-basierte Optimierung von Pyrrolidin-Carbonsäureamiden als Mycobacterium tuberculosis Enoyl-ACP-Reduktase-Inhibitoren</subfield><subfield code="c">submitted by: Yogesh Narkhede from Nasik, India</subfield></datafield><datafield tag="246" ind1="1" ind2="1"><subfield code="a">In silico Struktur-basierte Optimierung von Pyrrolidin-Carbonsäureamiden als Mycobacterium tuberculosis Enoyl-ACP-Reduktase-Inhibitoren</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Würzburg</subfield><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xix, 355 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">veröffentlicht 2018</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Julius-Maximilians-Universität Würzburg</subfield><subfield code="d">2017</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">Zusammenfassung in deutscher und englischer Sprache</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pyrrolidinderivate</subfield><subfield code="0">(DE-588)4176525-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tuberkelbakterium</subfield><subfield code="0">(DE-588)4186384-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Enoyl-acyl-carrier-protein-Reductase</subfield><subfield code="g">Enoyl-[acyl-carrier-protein]-Reductase</subfield><subfield code="0">(DE-588)4481400-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Tuberkelbakterium</subfield><subfield code="0">(DE-588)4186384-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Enoyl-acyl-carrier-protein-Reductase</subfield><subfield code="g">Enoyl-[acyl-carrier-protein]-Reductase</subfield><subfield code="0">(DE-588)4481400-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Pyrrolidinderivate</subfield><subfield code="0">(DE-588)4176525-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe, PDF</subfield><subfield code="o">urn:nbn:de:bvb:20-opus-152468</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-152468</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030401469</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV045009509 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T08:06:53Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030401469 |
| open_access_boolean | 1 |
| owner | DE-384 DE-473 DE-BY-UBG DE-703 DE-1051 DE-824 DE-29 DE-12 DE-91 DE-BY-TUM DE-19 DE-BY-UBM DE-1049 DE-92 DE-739 DE-898 DE-BY-UBR DE-355 DE-BY-UBR DE-706 DE-20 DE-1102 DE-860 DE-2174 |
| owner_facet | DE-384 DE-473 DE-BY-UBG DE-703 DE-1051 DE-824 DE-29 DE-12 DE-91 DE-BY-TUM DE-19 DE-BY-UBM DE-1049 DE-92 DE-739 DE-898 DE-BY-UBR DE-355 DE-BY-UBR DE-706 DE-20 DE-1102 DE-860 DE-2174 |
| physical | xix, 355 Seiten Illustrationen, Diagramme |
| psigel | ebook |
| publishDate | 2017 |
| publishDateSearch | 2017 |
| publishDateSort | 2017 |
| record_format | marc |
| spelling | Narkhede, Yogesh ca. 21. Jh. Verfasser (DE-588)1161195408 aut In silico structure-based optimisation of pyrrolidine carboxamides as Mycobacterium tuberculosis enoyl-ACP reductase inhibitors = In silico Struktur-basierte Optimierung von Pyrrolidin-Carbonsäureamiden als Mycobacterium tuberculosis Enoyl-ACP-Reduktase-Inhibitoren submitted by: Yogesh Narkhede from Nasik, India In silico Struktur-basierte Optimierung von Pyrrolidin-Carbonsäureamiden als Mycobacterium tuberculosis Enoyl-ACP-Reduktase-Inhibitoren Würzburg 2017 xix, 355 Seiten Illustrationen, Diagramme txt rdacontent n rdamedia nc rdacarrier veröffentlicht 2018 Dissertation Julius-Maximilians-Universität Würzburg 2017 Zusammenfassung in deutscher und englischer Sprache Pyrrolidinderivate (DE-588)4176525-4 gnd rswk-swf Tuberkelbakterium (DE-588)4186384-7 gnd rswk-swf Enoyl-acyl-carrier-protein-Reductase Enoyl-[acyl-carrier-protein]-Reductase (DE-588)4481400-8 gnd rswk-swf Arzneimitteldesign (DE-588)4278218-1 gnd rswk-swf (DE-588)4113937-9 Hochschulschrift gnd-content Tuberkelbakterium (DE-588)4186384-7 s Enoyl-acyl-carrier-protein-Reductase Enoyl-[acyl-carrier-protein]-Reductase (DE-588)4481400-8 s Pyrrolidinderivate (DE-588)4176525-4 s Arzneimitteldesign (DE-588)4278218-1 s DE-604 Erscheint auch als Online-Ausgabe, PDF urn:nbn:de:bvb:20-opus-152468 https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-152468 Resolving-System kostenfrei Volltext |
| spellingShingle | Narkhede, Yogesh ca. 21. Jh In silico structure-based optimisation of pyrrolidine carboxamides as Mycobacterium tuberculosis enoyl-ACP reductase inhibitors = In silico Struktur-basierte Optimierung von Pyrrolidin-Carbonsäureamiden als Mycobacterium tuberculosis Enoyl-ACP-Reduktase-Inhibitoren Pyrrolidinderivate (DE-588)4176525-4 gnd Tuberkelbakterium (DE-588)4186384-7 gnd Enoyl-acyl-carrier-protein-Reductase Enoyl-[acyl-carrier-protein]-Reductase (DE-588)4481400-8 gnd Arzneimitteldesign (DE-588)4278218-1 gnd |
| subject_GND | (DE-588)4176525-4 (DE-588)4186384-7 (DE-588)4481400-8 (DE-588)4278218-1 (DE-588)4113937-9 |
| title | In silico structure-based optimisation of pyrrolidine carboxamides as Mycobacterium tuberculosis enoyl-ACP reductase inhibitors = In silico Struktur-basierte Optimierung von Pyrrolidin-Carbonsäureamiden als Mycobacterium tuberculosis Enoyl-ACP-Reduktase-Inhibitoren |
| title_alt | In silico Struktur-basierte Optimierung von Pyrrolidin-Carbonsäureamiden als Mycobacterium tuberculosis Enoyl-ACP-Reduktase-Inhibitoren |
| title_auth | In silico structure-based optimisation of pyrrolidine carboxamides as Mycobacterium tuberculosis enoyl-ACP reductase inhibitors = In silico Struktur-basierte Optimierung von Pyrrolidin-Carbonsäureamiden als Mycobacterium tuberculosis Enoyl-ACP-Reduktase-Inhibitoren |
| title_exact_search | In silico structure-based optimisation of pyrrolidine carboxamides as Mycobacterium tuberculosis enoyl-ACP reductase inhibitors = In silico Struktur-basierte Optimierung von Pyrrolidin-Carbonsäureamiden als Mycobacterium tuberculosis Enoyl-ACP-Reduktase-Inhibitoren |
| title_full | In silico structure-based optimisation of pyrrolidine carboxamides as Mycobacterium tuberculosis enoyl-ACP reductase inhibitors = In silico Struktur-basierte Optimierung von Pyrrolidin-Carbonsäureamiden als Mycobacterium tuberculosis Enoyl-ACP-Reduktase-Inhibitoren submitted by: Yogesh Narkhede from Nasik, India |
| title_fullStr | In silico structure-based optimisation of pyrrolidine carboxamides as Mycobacterium tuberculosis enoyl-ACP reductase inhibitors = In silico Struktur-basierte Optimierung von Pyrrolidin-Carbonsäureamiden als Mycobacterium tuberculosis Enoyl-ACP-Reduktase-Inhibitoren submitted by: Yogesh Narkhede from Nasik, India |
| title_full_unstemmed | In silico structure-based optimisation of pyrrolidine carboxamides as Mycobacterium tuberculosis enoyl-ACP reductase inhibitors = In silico Struktur-basierte Optimierung von Pyrrolidin-Carbonsäureamiden als Mycobacterium tuberculosis Enoyl-ACP-Reduktase-Inhibitoren submitted by: Yogesh Narkhede from Nasik, India |
| title_short | In silico structure-based optimisation of pyrrolidine carboxamides as Mycobacterium tuberculosis enoyl-ACP reductase inhibitors |
| title_sort | in silico structure based optimisation of pyrrolidine carboxamides as mycobacterium tuberculosis enoyl acp reductase inhibitors in silico struktur basierte optimierung von pyrrolidin carbonsaureamiden als mycobacterium tuberculosis enoyl acp reduktase inhibitoren |
| title_sub | = In silico Struktur-basierte Optimierung von Pyrrolidin-Carbonsäureamiden als Mycobacterium tuberculosis Enoyl-ACP-Reduktase-Inhibitoren |
| topic | Pyrrolidinderivate (DE-588)4176525-4 gnd Tuberkelbakterium (DE-588)4186384-7 gnd Enoyl-acyl-carrier-protein-Reductase Enoyl-[acyl-carrier-protein]-Reductase (DE-588)4481400-8 gnd Arzneimitteldesign (DE-588)4278218-1 gnd |
| topic_facet | Pyrrolidinderivate Tuberkelbakterium Enoyl-acyl-carrier-protein-Reductase Enoyl-[acyl-carrier-protein]-Reductase Arzneimitteldesign Hochschulschrift |
| url | https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-152468 |
| work_keys_str_mv | AT narkhedeyogesh insilicostructurebasedoptimisationofpyrrolidinecarboxamidesasmycobacteriumtuberculosisenoylacpreductaseinhibitorsinsilicostrukturbasierteoptimierungvonpyrrolidincarbonsaureamidenalsmycobacteriumtuberculosisenoylacpreduktaseinhibitoren AT narkhedeyogesh insilicostrukturbasierteoptimierungvonpyrrolidincarbonsaureamidenalsmycobacteriumtuberculosisenoylacpreduktaseinhibitoren |